<html>

<head>
    <link href="./static/vendor/bootstrap/css/bootstrap.css" rel="stylesheet">
    <link href="./static/css/outliers.css" rel="stylesheet">
    <meta charset="UTF-8">
</head>

<body>
    <div class="container">
        <h1>Static outliers for Market Surgery</h1>
        <p>There is substantial variation in prescribing behaviours, across various different areas of medicine. Some variation can be explained by demographic changes, or local policies or guidelines, but much of the remaining variation is less easy to
            explain. At <a href="https://openprescribing.net/">OpenPrescribing</a> we are piloting a number of data-driven approaches to: identify unusual prescribing, collect feedback on this prescribing to inform development of new tools to support
            prescribers and organisations to audit and review prescribing.</p>
        <p>The below reports have been developed to use “z-scores” to automatically identify prescribing patterns at a chemical level which are furthest away from “typical prescribing” and can be classified as an “outlier”. It is important to remember that
            this information was generated automatically and it is therefore likely that some of the behaviour is warranted. This report seeks only to collect information about where this variation may be warranted and where it might not. Our full analytical
            method code is openly available on GitHub <a href="https://github.com/ebmdatalab/outliers/">here</a> but briefly we calculate the number of prescriptions for each chemical in the BNF coding system using the BNF subparagraph as a denominator.
            We used the time period from April 2021 to August 2021. We then calculate the mean and standard deviation for each numerator and denominator pair across all practices/CCGs/PCNs. From this we can calculate the “z-score”, which is a measure
            of how many standard deviations a given practice/CCG/PCN is from the population mean. We then rank your “z-scores” to find the top 5 results where prescribing is an outlier for prescribing higher than its peers and those where it is an outlier
            for prescribing lower than its peers.</p>
        <p>The DataLab is keen to hear your feedback on the results. You can do this by completing the following <a href="https://docs.google.com/forms/d/e/1FAIpQLSeH4ai_qyetAY4UAgZSWGnYQHkXNr9efFBmQvdrBi5uuXvgnQ/viewform?usp=pp_url&entry.2016356131=+">survey</a>            or emailing us at
            <a href="mailto:ebmdatalab@phc.ox.ac.uk?subject=OpenPrescribing%20outliers%20feedback">ebmdatalab@phc.ox.ac.uk</a>. Please DO NOT INCLUDE IDENTIFIABLE PATIENT information in your feedback. All feedback is helpful, you can send short or detailed
            feedback.
        </p>
        <h2>Prescribing where Market Surgery is higher than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_high">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D82016&amp;numIds=1001040A0&amp;denomIds=10.1.4&amp;selectedTab=summary">Benzbromarone</a><button type="button" data-toggle="collapse" data-target="#table_high_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>4</td>
      <td>Gout and cytotoxic induced hyperiuicaemia</td>
      <td>835</td>
      <td>0.00</td>
      <td>0.0</td>
      <td>0.00</td>
      <td>13.80</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D82016&amp;numIds=1001040A0AAAAAA&amp;denomIds=10.1.4&amp;selectedTab=summary" target="_blank">Benzbromarone 100mg tablets : 4</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D82016&amp;numIds=0407020H0&amp;denomIds=4.7.2&amp;selectedTab=summary">Dipipanone hydrochloride</a><button type="button" data-toggle="collapse" data-target="#table_high_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>6</td>
      <td>Opioid analgesics</td>
      <td>1368</td>
      <td>0.00</td>
      <td>0.0</td>
      <td>0.00</td>
      <td>9.22</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D82016&amp;numIds=0407020H0AAABAB&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Dipipanone 10mg / Cyclizine 30mg tablets : 6</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D82016&amp;numIds=0105020B0&amp;denomIds=1.5.2&amp;selectedTab=summary">Hydrocortisone acetate</a><button type="button" data-toggle="collapse" data-target="#table_high_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>1</td>
      <td>Corticosteroids</td>
      <td>16</td>
      <td>0.06</td>
      <td>0.0</td>
      <td>0.01</td>
      <td>7.78</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D82016&amp;numIds=0105020B0AAAAAA&amp;denomIds=1.5.2&amp;selectedTab=summary" target="_blank">Hydrocortisone 10% foam aerosol enema : 1</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D82016&amp;numIds=0402010P0&amp;denomIds=4.2.1&amp;selectedTab=summary">Pericyazine</a><button type="button" data-toggle="collapse" data-target="#table_high_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>175</td>
      <td>Antipsychotic drugs</td>
      <td>1216</td>
      <td>0.14</td>
      <td>0.0</td>
      <td>0.02</td>
      <td>7.27</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D82016&amp;numIds=0402010P0AAADAD&amp;denomIds=4.2.1&amp;selectedTab=summary" target="_blank">Pericyazine 2.5mg tablets : 168</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D82016&amp;numIds=0402010P0AAAEAE&amp;denomIds=4.2.1&amp;selectedTab=summary" target="_blank">Pericyazine 10mg tablets : 7</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D82016&amp;numIds=0407020L0&amp;denomIds=4.7.2&amp;selectedTab=summary">Meptazinol hydrochloride</a><button type="button" data-toggle="collapse" data-target="#table_high_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>108</td>
      <td>Opioid analgesics</td>
      <td>1368</td>
      <td>0.08</td>
      <td>0.0</td>
      <td>0.01</td>
      <td>7.14</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
  <tr id="table_high_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D82016&amp;numIds=0407020L0AAABAB&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Meptazinol 200mg tablets : 108</a></div></td></tr></tbody></table>

        <h2>Prescribing where Market Surgery is lower than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_low">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D82016&amp;numIds=0205051R0&amp;denomIds=2.5.5&amp;selectedTab=summary">Ramipril</a><button type="button" data-toggle="collapse" data-target="#table_low_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>1658</td>
      <td>Angiotensin-converting enzyme inhibitors</td>
      <td>5049</td>
      <td>0.33</td>
      <td>0.69</td>
      <td>0.17</td>
      <td>-2.17</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D82016&amp;numIds=0205051R0AAAAAA&amp;denomIds=2.5.5&amp;selectedTab=summary" target="_blank">Ramipril 1.25mg capsules : 330</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D82016&amp;numIds=0205051R0AAABAB&amp;denomIds=2.5.5&amp;selectedTab=summary" target="_blank">Ramipril 2.5mg capsules : 518</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D82016&amp;numIds=0205051R0AAACAC&amp;denomIds=2.5.5&amp;selectedTab=summary" target="_blank">Ramipril 5mg capsules : 376</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D82016&amp;numIds=0205051R0AAADAD&amp;denomIds=2.5.5&amp;selectedTab=summary" target="_blank">Ramipril 10mg capsules : 335</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D82016&amp;numIds=0205051R0AAAMAM&amp;denomIds=2.5.5&amp;selectedTab=summary" target="_blank">Ramipril 5mg tablets : 45</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D82016&amp;numIds=0205051R0AAANAN&amp;denomIds=2.5.5&amp;selectedTab=summary" target="_blank">Ramipril 10mg tablets : 26</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D82016&amp;numIds=0205051R0AAALAL&amp;denomIds=2.5.5&amp;selectedTab=summary" target="_blank">Ramipril 2.5mg tablets : 16</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D82016&amp;numIds=0205051R0AAAKAK&amp;denomIds=2.5.5&amp;selectedTab=summary" target="_blank">Ramipril 1.25mg tablets : 6</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D82016&amp;numIds=0205051R0AAATAT&amp;denomIds=2.5.5&amp;selectedTab=summary" target="_blank">Ramipril 2.5mg/5ml oral solution sugar free : 6</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D82016&amp;numIds=0202040B0&amp;denomIds=2.2.4&amp;selectedTab=summary">Co-amilofruse (Amiloride hydrochloride/frusemide)</a><button type="button" data-toggle="collapse" data-target="#table_low_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>0</td>
      <td>Potassium sparing diuretics and compounds</td>
      <td>24</td>
      <td>0.00</td>
      <td>0.68</td>
      <td>0.33</td>
      <td>-2.07</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D82016&amp;numIds=0107020P0&amp;denomIds=1.7.2&amp;selectedTab=summary">Prednisolone</a><button type="button" data-toggle="collapse" data-target="#table_low_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>0</td>
      <td>Copound haemorrhoidal preparations with corticosteroid</td>
      <td>86</td>
      <td>0.00</td>
      <td>0.41</td>
      <td>0.24</td>
      <td>-1.71</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D82016&amp;numIds=1302011L0&amp;denomIds=13.2.1&amp;selectedTab=summary">Light liquid paraffin</a><button type="button" data-toggle="collapse" data-target="#table_low_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>0</td>
      <td>Emollient bath and shower preparations</td>
      <td>29</td>
      <td>0.00</td>
      <td>0.35</td>
      <td>0.21</td>
      <td>-1.68</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D82016&amp;numIds=0205052N0&amp;denomIds=2.5.5&amp;selectedTab=summary">Losartan potassium</a><button type="button" data-toggle="collapse" data-target="#table_low_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>417</td>
      <td>Angiotensin-II receptor antagonists</td>
      <td>2105</td>
      <td>0.20</td>
      <td>0.50</td>
      <td>0.19</td>
      <td>-1.62</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
  <tr id="table_low_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D82016&amp;numIds=0205052N0AAAAAA&amp;denomIds=2.5.5&amp;selectedTab=summary" target="_blank">Losartan 25mg tablets : 110</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D82016&amp;numIds=0205052N0AAABAB&amp;denomIds=2.5.5&amp;selectedTab=summary" target="_blank">Losartan 50mg tablets : 229</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D82016&amp;numIds=0205052N0AAADAD&amp;denomIds=2.5.5&amp;selectedTab=summary" target="_blank">Losartan 100mg tablets : 62</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D82016&amp;numIds=0205052N0AAAHAH&amp;denomIds=2.5.5&amp;selectedTab=summary" target="_blank">Losartan 12.5mg tablets : 13</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D82016&amp;numIds=0205052N0BBACAD&amp;denomIds=2.5.5&amp;selectedTab=summary" target="_blank">Cozaar 100mg tablets : 3</a></div></td></tr></tbody></table>

    </div>
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.11.3/jquery.min.js"></script>
    <script src="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.5/js/bootstrap.min.js"></script>
</body>

</html>